Asklepios Biopharmaceuticalinc Askbiois A Clinical Stage Gene Therapy Company Based In Research Triangle Parknorth Carolinafounded In 2001 By Drrjude Samulskia Leader In Adeno Associated Virusaavresearchaskbio Focuses On Developing Aav Based Therapies For Genetic And Complex Disordersthe Company Aims To Enhance Patient Lives Through Innovative Genetic Medicine Askbio Utilizes Its Proprietary Pro10A C Manufacturing Processwhich Is Designed For Scalable And Efficient Aav Productionthe Company Has An Extensive Library Of Aav Capsids And Promoterssupported By Over 500 Patentsits Pipeline Includes Investigational Therapies For Neuromuscular Disorderscardiovascular Diseaseshemophiliaand Central Nervous System Disordersaskbio Collaborates With Academic Institutions And Biopharmaceutical Companies To Advance Gene Therapy Research And Has Received Recognition For Its Contributions To The Fieldin 2020Bayer Acquired Askbiowhich Continues To Operate As An Independent Subsidiary
